The results indicate that MMP-9 offers particular promise as a biomarker of post-stroke cognitive recovery: MMP-9 level in plasma decreased during three-week rehabilitation, with the changes correlating with improvements in cognitive function. The gene discussed is MMP9; the disease is stroke disorder.